GlassScriptPhysician profile
Luis A Castaneda
NPI 1962668509
$341.84
in general payments reported to CMS, 2019-2025
6 companies · $73.89 in 2025
The $73.89 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $104 · 2020: $15.74 · 2021: $41.28 · 2022: $55.20 · 2023: $34.98 · 2024: $17.09 · 2025: $73.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $125.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $131.36 | 2019-2024 | Bridion |
| Edwards Lifesciences Corporation | $85.66 | 2019 | |
| Medtronic, INC. | $51.99 | 2022-2025 | Nim-Response |
| Masimo Corporation | $43.15 | 2023-2025 | Sedline |
| Octapharma USA, INC. | $18.19 | 2025 | Fibryga |
| Pacira Pharmaceuticals Incorporated | $11.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Castaneda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.